← Eichor
Condition: Clonal Cytopenia Of Undetermined Significance Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Clonal Cytopenia Of Undetermined Significance

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Early Intervention in High Risk CCUS
EARLY_Phase 1 · 1 location(s) · Lachelle D. Weeks, MD, PhD · NCT06802146A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and
Phase 2 · 2 location(s) · M.D. Anderson Cancer Center · NCT06566742Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
Phase N/A · 1 location(s) · University of Washington · NCT06295965Luspatercept for Clonal Cytopenias of Uncertain Significance
Phase 2 · 1 location(s) · Weill Medical College of Cornell University · NCT06788691Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
NA · 3 location(s) · Mayo Clinic · NCT02958462Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Le
Phase 2 · 4 location(s) · Mayo Clinic · NCT03418038Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT06240754Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
Phase 2 · 1 location(s) · Kirsten Grønbæk · NCT04741945Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT07675967Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)
Phase 2 · 1 location(s) · University of Colorado, Denver · NCT07579429Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT05483010Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPA
Phase 2 · 6 location(s) · Uma Borate · NCT05641831CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research
Phase N/A · 1 location(s) · Clinical Hub for Interventional Research (CHOIR) · NCT07313059CHIP/CCUS Natural History Protocol
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT04102423Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk M
Phase 2 · 2 location(s) · University of Southern California · NCT06063486
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.